Search | Page 10 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes

    ... to treat anemia in patients with lower-risk myelodysplastic syndromes (MDS) was evaluated in a phase 3 trial. Eligible patients had ...

    Research Article last updated 07/11/2017 - 10:16am.

  2. Allogeneic Hematopoietic Stem Cell Transplantation is Underutilized in Older Patients with Myelodysplastic Syndromes

    ... transplantation (HCT) is the only curative treatment for myelodysplastic syndrome (MDS). The proportion of MDS patients referred for ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 04/14/2017 - 9:28am.

  3. Myelodysplastic syndromes: What do hospitalists need to know?

    ... Myelodysplastic syndromes (MDS) comprise a heterogeneous group of clonal hematopoietic stem ...

    Research Article last updated 06/20/2013 - 10:59am.

  4. Effectiveness and safety of different azacitidine dosage regimens in patients with myelodysplastic syndromes or acute myeloid leukemia

    ... in patients with World Health Organization-defined myelodysplastic syndromes , or acute myeloid leukemia with 20-30% bone marrow ...

    Research Article last updated 05/22/2014 - 9:28am.

  5. Asthma and risk of myelodysplastic syndromes: a population-based cohort study

    ... BACKGROUND: Risk factors for the development of myelodysplastic syndromes (MDS) include age, exposure to ionising radiation, and cytotoxic ...

    Research Article last updated 12/09/2016 - 2:43pm.

  6. Can iron overload in patients with lower-risk myelodysplastic syndromes be reduced using erythropoiesis-stimulating agents?

    ... Iron overload (IOL) portends inferior outcome in myelodysplastic syndromes (MDS). Erythropoiesis-stimulating agents (ESA) may reduce ...

    Research Article last updated 12/09/2015 - 8:52am.

  7. Implementation of erythroid lineage analysis by flow cytometry in diagnostic models for myelodysplastic syndromes

    ... analysis is a recommended tool in the diagnosis of myelodysplastic syndromes . Current flow cytometric approaches evaluate the (im)mature ...

    Research Article last updated 10/06/2016 - 11:33am.

  8. Erythropoietin administration is associated with improved T-cell properties in patients with myelodysplastic syndromes

    ... The immune system is impaired in myelodysplastic syndromes (MDS) and plays a role in the pathogenesis of the disease. Here ...

    Research Article last updated 12/09/2016 - 3:05pm.

  9. Use of eltrombopag for treatment of myelodysplastic syndromes

    ... Bone Marrow Diseases:  myelodysplastic syndromes (MDS) ...

    Research Article last updated 03/22/2017 - 10:31am.

  10. The immune landscape of myelodysplastic syndromes

    ... Even though the pathogenesis of myelodysplastic syndromes (MDS) is dominated by specific molecular defects involving ...

    Research Article last updated 11/28/2016 - 9:37am.